Skip to main content

Table 4 The serum expression level of FGA, APOA-1 and AHSG in different groups

From: Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer

  Control group (n = 28) I/II GC-pre (n = 16) III/IV GC-pre (n = 26) I/II GC-post (n = 16) III/IV GC-post (n = 26) CRC (n = 30) HCC (n = 30)
FGA (ng/ml) 406.80 ± 42.52 (330.14–490.51) 544.05 ± 53.74 (447.79–642.26) 814.19 ± 85.74 (676.96–950.09) 403.54 ± 46.80 (428.47–598.98) 664.13 ± 63.38 (556.04–755.03) 630.94 ± 96.46 (429.35–800.72) 596.70 ± 67.63 (450.21–779.29)
AHSG (μg/ml) 291.83 ± 47.24 (204.48–375.66) 353.74 ± 49.51 (244.96–441.11) 455.79 ± 59.74 (385.38–606.92) 324.74 ± 41.81 (244.41–401.99) 420.17 ± 53.98 (354.95–548.11) 337.34 ± 49.78 (224.17–423.79) 351.26 ± 41.66 (262.71–441.91)
AOPA-I (μg/ml) 3.44 ± 0.96 (2.03–5.44) 5.91 ± 1.19 (4.66–8.23) 3.71 ± 0.79 (2.67–6.19) 4.52 ± 1.14 (3.21–6.92) 3.31 ± 0.82 (1.97–5.02) 3.82 ± 0.65 (2.80–5.67) 2.25 ± 0.93 (0.84–4.10)